Cargando…
Surgical management of bilateral hip fractures in a patient with fibrodysplasia ossificans progressiva treated with the RAR-γ agonist palovarotene: a case report
BACKGROUND: Fibrodysplasia ossificans progressiva (FOP) is an ultra-rare disorder marked by painful, recurrent flare-ups and heterotopic ossification (HO) in soft and connective tissues, which can be idiopathic or provoked by trauma, illness, inflammation, or surgery. There are currently no effectiv...
Autores principales: | Singh, Sukhmani, Kidane, Joseph, Wentworth, Kelly L., Motamedi, Daria, Morshed, Saam, Schober, Andrew E., Hsiao, Edward C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126417/ https://www.ncbi.nlm.nih.gov/pubmed/32245464 http://dx.doi.org/10.1186/s12891-020-03240-2 |
Ejemplares similares
-
MON-348 Surgical Management of Bilateral Hip Fracture in a Patient with Fibrodysplasia Ossificans Progressiva Treated with Palovarotene
por: Singh, Sukhmani, et al.
Publicado: (2020) -
Study methodology and insights from the palovarotene clinical development program in fibrodysplasia ossificans progressiva
por: Pignolo, Robert J., et al.
Publicado: (2023) -
Fibrodysplasia ossificans progressiva
por: Smit, Chané, et al.
Publicado: (2023) -
Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo‐Controlled, Double‐Blind Phase 2 Trial
por: Pignolo, Robert J., et al.
Publicado: (2022) -
ODP108 Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva: Methodology of the Phase III Open-Label PIVOINE Rollover Trial
por: Artyomenko, Alex, et al.
Publicado: (2022)